Genflow Biosciences PLC (GENF)

London
2.25
0.00(0.00%)
  • Volume:
    260,508
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    2.25 - 2.25

GENF Overview

Prev. Close
2.25
Day's Range
2.25-2.25
Revenue
-
Open
2.25
52 wk Range
1.72-13.5
EPS
-0.007
Volume
260,508
Market Cap
6.44M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,271,922
P/E Ratio
-3.06
Beta
-
1-Year Change
-82.18%
Shares Outstanding
292,506,618
Next Earnings Date
-
What is your sentiment on Genflow Biosciences?
or
Market is currently closed. Voting is open during market hours.

Genflow Biosciences PLC News

Genflow Biosciences PLC Company Profile

Genflow Biosciences PLC Company Profile

Genflow Biosciences PLC is a United Kingdom-based preclinical biotechnology company. The Company is focused on developing gene therapies designed to target the ageing process and reduce and delay the incidence of age-related diseases and so improve health span and potentially life expectancy. The Company is engaged in developing products that address the growing medical need to treat the age-related diseases by using adeno-associated virus (AAV) vectors to deliver copies of its centenarian Sirtuin 6 (SIRT6) gene variant. The Company's product line includes GF-1002, GF-3001 and GF-4001. Its GF-1002 is a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The Company has operations in the United Kingdom and Belgium.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellStrong SellStrong SellSell
Technical IndicatorsStrong SellStrong SellSellBuySell
SummaryStrong SellStrong SellStrong SellNeutralSell